Assembly Biosciences, Inc. Profile Avatar - Palmy Investing

Assembly Biosciences, Inc.

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as co…

Biotechnology
US, South San Francisco [HQ]

Income Statements

Loading...
End of ASMB's Analysis
CIK: 1426800 CUSIP: 045396108 ISIN: US0453962070 LEI: - UEI: -
Secondary Listings
ASMB has no secondary listings inside our databases.